Growth Metrics

Merck (MRK) FCF Payout Ratio (2016 - 2026)

Merck has reported FCF Payout Ratio over the past 18 years, most recently at 0.72 for Q1 2026.

  • Quarterly FCF Payout Ratio fell 58.88% to 0.72 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was 0.58 through Mar 2026, up 25.14% year-over-year, with the annual reading at 0.66 for FY2025, 52.68% up from the prior year.
  • FCF Payout Ratio was 0.72 for Q1 2026 at Merck, down from 1.11 in the prior quarter.
  • Over five years, FCF Payout Ratio peaked at 5.58 in Q1 2023 and troughed at 2.49 in Q4 2023.
  • The 5-year median for FCF Payout Ratio is 0.56 (2022), against an average of 0.76.
  • The largest YoY upside for FCF Payout Ratio was 1108.06% in 2023 against a maximum downside of 567.33% in 2023.
  • A 5-year view of FCF Payout Ratio shows it stood at 0.53 in 2022, then tumbled by 567.33% to 2.49 in 2023, then soared by 131.15% to 0.78 in 2024, then soared by 42.51% to 1.11 in 2025, then crashed by 35.0% to 0.72 in 2026.
  • Per Business Quant, the three most recent readings for MRK's FCF Payout Ratio are 0.72 (Q1 2026), 1.11 (Q4 2025), and 0.3 (Q3 2025).